Cell-Based Assays for Modeling Xenogeneic Immune Responses.
Animals
Antigens, Heterophile
/ immunology
Biological Assay
/ methods
Cell Culture Techniques
Coculture Techniques
Cytokines
/ metabolism
Cytotoxicity, Immunologic
Graft Rejection
/ diagnosis
Heterografts
/ immunology
Humans
Killer Cells, Natural
/ immunology
Swine
T-Lymphocytes
/ immunology
Transplantation Immunology
Transplantation, Heterologous
/ adverse effects
Cytokines
Human
Immune response
Monocytes
NK cells
Pig
T cells
Journal
Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
1
2
2020
pubmed:
1
2
2020
medline:
28
1
2021
Statut:
ppublish
Résumé
Research in xenotransplantation implies a high experimental complexity comprising molecular, cellular, and in vivo studies to investigate the mechanisms of xenograft immune rejection and functional failure, as well as the strategies to counteract them. After major advances associated with the identification of the carbohydrate xenoantigens and their elimination through genomic edition of the source pigs, the study of the cellular immune response against the xenograft is gaining particular attention. Xenogeneic cell-based assays that put together pig cells and human leukocytes such as monocytes, NK cells, and T cells are relevant to address this hurdle. Thus, we describe here coculture, co-stimulatory, and cytotoxicity assays for investigating the cellular and molecular mechanisms of xenograft rejection. These techniques allow elucidating the key pathways that take place during the xenogeneic immune response in a simplified setting. Treatment with either pro-inflammatory or anti-inflammatory cytokines can be used for studying the regulation of adhesion, co-stimulatory molecules, and receptors involved in triggering the immune response under various conditions. Furthermore, these assays can be used for the follow-up of the immune response of in vivo studies as well as for the development of tolerogenic approaches that promote xenograft survival.
Identifiants
pubmed: 32002904
doi: 10.1007/978-1-0716-0255-3_7
doi:
Substances chimiques
Antigens, Heterophile
0
Cytokines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM